The third edition of “Biomarker Days” took place at the University of Montpellier’s new Faculty of Medicine building on June 24-25, 2019, attracting over  350 participants for the two days. This year, the not-to-be-missed event was devoted to oncology and was co-organized by the Regional Agency for Economic Development AD’OCC, Eurobiomed competitiveness cluster, MUSE I-Site’s KIM “Biomarkers & Therapy”, and SIRIC Montpellier Cancer.

The rich program brought together major regional national players in scientific research and promoted the emergence of novel collaborations among fundamental researchers, clinicians, and industry researchers.

The first day focused on advances in cancer research and biomarker discovery as well as on the development of new strategies for cancer management. The second day concentrated more on the integration of artificial intelligence in cancer diagnosis and treatment, finishing with the organization of technological events.

One of the highlights June 24 was the signature of a consortium agreement for SIRIC Montpellier Cancer that unites 600 clinicians and researchers in their progress to fight cancer.

Exhibitors and poster sessions

13 exhibitors were present, including 11 pharmaceutical laboratories, regional biobanks, and the national life sciences and health alliance Aviesan. Poster sessions were organized to give additional visibility to biomarker projects.

Key elements:

  • More than 350 participants for two days
  • Institutional session including presidents of the Montpellier Universities, Montpellier University Hospital Center, Region, and Montpellier Méditerranée Métropole
  • 38 high-level speakers
  • 13 exhibitors
  • 7 poster sessions